These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9372009)

  • 1. Myelodysplastic syndrome.
    Legare RD; Gilliland DG
    Curr Opin Hematol; 1995 Jul; 2(4):283-92. PubMed ID: 9372009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of therapy-related leukemia and myelodysplastic syndrome.
    Kantarjian HM; Estey EH; Keating MJ
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):81-107. PubMed ID: 7680643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-related myelodysplastic syndrome after allogeneic BMT: successful treatment by donor lymphocyte infusions.
    Roos-Weil D; Nguyen S; Uzunov M; Bories D; Chapiro E; Nguyen-Khac F; Vernant JP; Dhédin N
    Bone Marrow Transplant; 2010 Sep; 45(9):1471-3. PubMed ID: 20098458
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in biology and treatment of myelodysplasia.
    Heyman MR
    Curr Opin Oncol; 1991 Feb; 3(1):44-53. PubMed ID: 1710505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myelodysplastic syndromes: current approaches to therapy.
    Cheson BD
    Ann Intern Med; 1990 Jun; 112(12):932-41. PubMed ID: 2187393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndromes complicating hematopoietic stem cell transplantation.
    Fassas AB; Tricot G
    Cancer Treat Res; 2001; 108():169-84. PubMed ID: 11702599
    [No Abstract]   [Full Text] [Related]  

  • 7. Should patients with high-risk or transformed myelodysplastic syndrome proceed directly to allogeneic transplant without prior cytoreduction by remission-induction chemotherapy or hypomethylating agent therapy?
    de Witte TM; Bowen D; Robin M; Malcovati L; Mufti G; Niederwieser D; Yakoubagha I; Kröger N;
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S42-5. PubMed ID: 25486954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current treatment methods in myelodysplastic syndromes].
    Klimenko VI; Liubarets TF
    Lik Sprava; 1996; (10-12):20-6. PubMed ID: 9138806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent advances in the treatment of myelodysplastic syndromes].
    Gelsi-Boyer V; Vey N
    Rev Med Interne; 2006 Aug; 27(8):600-9. PubMed ID: 16713027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.
    Woods WG; Kobrinsky N; Buckley J; Neudorf S; Sanders J; Miller L; Barnard D; Benjamin D; DeSwarte J; Kalousek D
    J Clin Oncol; 1993 Aug; 11(8):1448-57. PubMed ID: 8336184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndromes. Pathogenesis, diagnosis and treatment.
    Noël P; Solberg LA
    Crit Rev Oncol Hematol; 1992; 12(3):193-215. PubMed ID: 1379818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive chemotherapy for patients with high-risk myelodysplastic syndrome.
    Beran M
    Int J Hematol; 2000 Aug; 72(2):139-50. PubMed ID: 11039661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation.
    Yakoub-Agha I; de La Salmonière P; Ribaud P; Sutton L; Wattel E; Kuentz M; Jouet JP; Marit G; Milpied N; Deconinck E; Gratecos N; Leporrier M; Chabbert I; Caillot D; Damaj G; Dauriac C; Dreyfus F; François S; Molina L; Tanguy ML; Chevret S; Gluckman E
    J Clin Oncol; 2000 Mar; 18(5):963-71. PubMed ID: 10694545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation (7;9)(q22;q34) in therapy-related myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloblastic leukemia.
    Yamamoto K; Yakushijin K; Kawamori Y; Minagawa K; Katayama Y; Matsui T
    Cancer Genet Cytogenet; 2007 Jul; 176(1):61-6. PubMed ID: 17574966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Cord Blood Transplantation in a Werner Syndrome Patient with High-risk Myelodysplastic Syndrome.
    Hayashi K; Tasaka T; Kondo T; Ishikawa Y; Goto M; Matsuhashi Y; Sadahira Y; Sugihara T; Wada H
    Intern Med; 2019 Jan; 58(1):109-113. PubMed ID: 30146558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. pathogenesis and pathophysiology of bone-marrow failure; 3. Myelodysplastic syndrome].
    Mitani K
    Nihon Naika Gakkai Zasshi; 2012 Jul; 101(7):1898-905. PubMed ID: 22896992
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.
    Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N;
    Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [9th Antonio Raichs memorial lecture. Myelodysplastic syndromes].
    Giralt M
    Sangre (Barc); 1997 Feb; 42(1):63-71. PubMed ID: 9229805
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
    Le Beau MM; Albain KS; Larson RA; Vardiman JW; Davis EM; Blough RR; Golomb HM; Rowley JD
    J Clin Oncol; 1986 Mar; 4(3):325-45. PubMed ID: 3950675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.